Next Article in Journal
Muscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within
Next Article in Special Issue
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
Previous Article in Journal
Dynamic Protein S-Acylation in Plants
 
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 20
Issue 3
10.3390/ijms20030561
ijms-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Review

Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer

by
Akihiro Ohmoto
1,*,
Shinichi Yachida
1,2 and
Chigusa Morizane
3
1
Laboratory of Clinical Genomics, National Cancer Center Research Institute, Tokyo 1040045, Japan
2
Department of Cancer Genome Informatics, Graduate School of Medicine/Faculty of Medicine, Osaka University, Osaka 5650871, Japan
3
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo 1040045, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 561; https://doi.org/10.3390/ijms20030561
Received: 26 December 2018 / Revised: 25 January 2019 / Accepted: 28 January 2019 / Published: 29 January 2019
(This article belongs to the Special Issue Cell and Molecular Biology of Pancreatic Disorders 2019)
View Full-Text Download PDF
Browse Figure
Review Reports

Abstract

Pancreatic cancer (PC) is one of the most devastating malignancies; it has a 5-year survival rate of only 9%, and novel treatment strategies are urgently needed. While most PC cases occur sporadically, PC associated with hereditary syndromes or familial PC (FPC; defined as an individual having two or more first-degree relatives diagnosed with PC) accounts for about 10% of cases. Hereditary cancer syndromes associated with increased risk for PC include Peutz-Jeghers syndrome, hereditary pancreatitis, familial atypical multiple mole melanoma, familial adenomatous polyposis, Lynch syndrome and hereditary breast and ovarian cancer syndrome. Next-generation sequencing of FPC patients has uncovered new susceptibility genes such as PALB2 and ATM, which participate in homologous recombination repair, and further investigations are in progress. Previous studies have demonstrated that some sporadic cases that do not fulfil FPC criteria also harbor similar mutations, and so genomic testing based on family history might overlook some susceptibility gene carriers. There are no established screening procedures for high-risk unaffected cases, and it is not clear whether surveillance programs would have clinical benefits. In terms of treatment, poly (ADP-ribose) polymerase inhibitors for BRCA-mutated cases or immune checkpoint inhibitors for mismatch repair deficient cases are promising, and clinical trials of these agents are underway. View Full-Text
Keywords: hereditary cancer syndrome; Lynch syndrome; familial pancreatic cancer; next-generation sequencing; germline mutation; surveillance; PARP inhibitor; immune checkpoint inhibitor hereditary cancer syndrome; Lynch syndrome; familial pancreatic cancer; next-generation sequencing; germline mutation; surveillance; PARP inhibitor; immune checkpoint inhibitor
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
SciFeed

Share and Cite

MDPI and ACS Style

Ohmoto, A.; Yachida, S.; Morizane, C. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Int. J. Mol. Sci. 2019, 20, 561. https://doi.org/10.3390/ijms20030561

AMA Style

Ohmoto A, Yachida S, Morizane C. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. International Journal of Molecular Sciences. 2019; 20(3):561. https://doi.org/10.3390/ijms20030561

Chicago/Turabian Style

Ohmoto, Akihiro, Shinichi Yachida, and Chigusa Morizane. 2019. "Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer" International Journal of Molecular Sciences 20, no. 3: 561. https://doi.org/10.3390/ijms20030561

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop